Ethical Compliance
FDC
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
medium
Revenue
4.4%
Debt
0%
Liquidity
1.1%
Revenue
Debt
Liquidity
4.4%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
Other Income | ₹10.91 |
Pharmaceutical Products | ₹1,935.20 |
Other Operating Income | ₹7.74 |
Questionable
INR Crores
Investment Gain | ₹60.35 |
Non Compliant
INR Crores
Interest Income | ₹30.37 |
INR Crores
Revenue from Questionable Sources: | ₹60.35 |
Revenue from Non Compliant Sources: | ₹30.37 |
Total: | ₹90.72 |
Total Revenue: | ₹2,044.58 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹90.72
₹2,044.58
= 4.4%
questionable
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.